Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib as Second Line Therapy in Metastatic Prostate Cancer
NCT00945477Phase 2Terminated
- Sponsor
- Illinois CancerCare
- Start
- Jul 2009
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in prostate cancer (PCa), sponsored by Illinois CancerCare. Started Jul 2009; status: terminated.
02
Drugs
pazopanib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00945477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00945477.